Virginia Retirement Systems
ESPR icon

Virginia Retirement Systems’s Esperion Therapeutics ESPR Stock Holding History

Virginia Retirement Systems’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-48,800
Closed -$588K – 1120
2021
Q3 		$588K Buy
+48,800
New +$710K 0.01% 764
2020
Q3 		– Sell
-11,700
Closed -$600K – 1108
2020
Q2 		$600K Buy
11,700
+5,200
+80% +$218K 0.01% 733
2020
Q1 		$205K Sell
6,500
-1,800
-22% -$95K ﹤0.01% 1018
2019
Q4 		$495K Sell
8,300
-4,300
-34% -$193K 0.01% 928
2019
Q3 		$462K Buy
12,600
+7,900
+168% +$313K 0.01% 919
2019
Q2 		$219K Buy
+4,700
New +$221K ﹤0.01% 1078
2018
Q2 		– Sell
-4,800
Closed -$347K – 1054
2018
Q1 		$347K Buy
+4,800
New +$352K ﹤0.01% 886
2017
Q1 		– Sell
-22,600
Closed -$283K – 1132
2016
Q4 		$283K Buy
22,600
+5,100
+29% +$60.7K ﹤0.01% 878
2016
Q3 		$242K Buy
+17,500
New +$198K ﹤0.01% 863

Other funds holding ESPR

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Virginia Retirement Systems's ESPR Position: Q4 2021 in Review

Virginia Retirement Systems sold out of Esperion Therapeutics (ESPR) in Q4 2021, closing a stake of 48,800 shares — an estimated $588K sold.

Virginia Retirement Systems first reported a position in ESPR in Q3 2016 and held it in 9 quarters. The position peaked at $600K in Q2 2020. 133 funds tracked by Wall St. Rank hold ESPR as of Q4 2021.

  • Virginia Retirement Systems reported no remaining Esperion Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 48,800 Esperion Therapeutics shares in Q4 2021, an estimated $588K.
  • Virginia Retirement Systems first reported a position in Esperion Therapeutics in Q3 2016 and held it in 9 quarters.
  • Virginia Retirement Systems's Esperion Therapeutics position peaked at $600K in Q2 2020.
  • 133 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2021.

Based on Virginia Retirement Systems's 13F filing for Q4 2021, filed 3 Feb 2022.